Fact CheckerSign in

NCT07297433Completed

Erector Spinae Plane Block in Laparoscopic Colorectal Cancer Surgery

Erector Spinae Plane Block in Laparoscopic Colorectal Cancer Surgery: Effects on Renal Blood Flow and Kidney Function

Source: ClinicalTrials.gov · Last updated 27 May 2026

Brief summary (registry, in English)

Our study will compare patients who underwent laparoscopic surgery for colorectal cancer with and without Erector Spinae Plane Block in terms of renal blood flow and renal function tests. In our study, which will be conducted by dividing patients into two groups, the investigators aim to demonstrate the effects of the erector spinae plane block on renal physiology by simultaneously monitoring renal blood flow during the intraoperative period using near-infrared spectroscopy and monitoring renal function in the postoperative period using NGAL, serum creatinine, and eGFR.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
9 Dec 2025
Start date
Jan 2025
Primary completion date
Apr 2026
Lead sponsor
Kayseri City Hospital
NCT number
NCT07297433

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From Jan 2025 to the primary completion date, Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Having a systemic infection or infection at the injection site
  • Having any disease related to bleeding time and clotting
  • Having a history of local anesthetic allergy

Age

  • Being under 18 years of age

Other

  • Patient refusal (ESPB for analgesic purposes)
  • Patients with a Body Mass Index (BMI) of 30 or above

Who the study is looking for

  • Age: 35-75 years old
  • Colorectal cancer surgery must be planned by a physician
  • No infection in the injection site
  • No history of any disease related to clotting or bleeding time
  • The patient must be a volunteer
  • No history of local anesthetic allergy

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kayseri Şehir Hastanesi
Coordinator of this site? Confirm its status
KayseriTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.